Squarepoint Ops LLC Makes New Investment in Inogen, Inc. (NASDAQ:INGN)

Squarepoint Ops LLC acquired a new position in shares of Inogen, Inc. (NASDAQ:INGN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 46,224 shares of the medical technology company's stock, valued at approximately $424,000. Squarepoint Ops LLC owned 0.19% of Inogen as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in INGN. AlphaQuest LLC bought a new stake in Inogen in the fourth quarter valued at about $43,000. Meeder Asset Management Inc. acquired a new stake in Inogen during the fourth quarter valued at approximately $56,000. Integrated Quantitative Investments LLC bought a new stake in shares of Inogen in the 4th quarter valued at approximately $92,000. Intech Investment Management LLC acquired a new position in shares of Inogen in the 4th quarter worth approximately $94,000. Finally, Ieq Capital LLC acquired a new position in shares of Inogen in the 4th quarter worth approximately $94,000. 89.94% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have weighed in on INGN. Needham & Company LLC upgraded Inogen from a "hold" rating to a "moderate buy" rating and set a $12.00 price target on the stock in a research report on Thursday, May 22nd. Wall Street Zen downgraded shares of Inogen from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, Stifel Nicolaus lowered their target price on shares of Inogen from $10.00 to $7.00 and set a "hold" rating on the stock in a report on Thursday, May 8th.

Inogen Price Performance

Shares of NASDAQ:INGN traded up $0.29 during trading on Friday, reaching $6.59. The stock had a trading volume of 183,114 shares, compared to its average volume of 240,426. The stock has a market capitalization of $177.19 million, a PE ratio of -2.93 and a beta of 1.64. Inogen, Inc. has a 52 week low of $5.70 and a 52 week high of $13.33. The business's 50-day moving average price is $6.72 and its 200 day moving average price is $8.44.

Inogen (NASDAQ:INGN - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The medical technology company reported ($0.25) earnings per share for the quarter, beating analysts' consensus estimates of ($0.52) by $0.27. Inogen had a negative return on equity of 27.38% and a negative net margin of 15.89%. The firm had revenue of $82.28 million during the quarter, compared to analysts' expectations of $79.57 million. Analysts forecast that Inogen, Inc. will post -1.73 EPS for the current year.

Inogen Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.